The Current Ratio as of November 2024 (TTM) for Sana Biotechnology, Inc. (SANA) is 4.47

According to Sana Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.47. This represents a change of -6.13% compared to the average of 4.76 of the last 4 quarters.

Sana Biotechnology, Inc. (SANA) Historical Current Ratio (quarterly & annually)

How has SANA Current Ratio performed in the past?

The mean historical Current Ratio of Sana Biotechnology, Inc. over the last ten years is 8.45. The current 4.47 Current Ratio has changed 5.19% with respect to the historical average. Over the past ten years (40 quarters), SANA's Current Ratio was at its highest in in the March 2021 quarter at 27.52. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Sana Biotechnology, Inc. (SANA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sana Biotechnology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sana Biotechnology, Inc. (SANA) Average Current Ratio

How has SANA Current Ratio performed in the past?

The current Current Ratio of Sana Biotechnology, Inc. (SANA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sana Biotechnology, Inc. (SANA) Current Ratio vs. Peers

How is SANA’s Current Ratio compared to its peers?

Sana Biotechnology, Inc.’s Current Ratio is less than Olema Pharmaceuticals, Inc. (7.10), less than Cullinan Oncology, Inc. (24.46), less than aTyr Pharma, Inc. (6.07), less than Zentalis Pharmaceuticals, Inc. (7.29), less than X4 Pharmaceuticals, Inc. (4.89), less than Galera Therapeutics, Inc. (5.63), less than Terns Pharmaceuticals, Inc. (32.99), less than Day One Biopharmaceuticals, Inc. (14.62), greater than HOOKIPA Pharma Inc. (3.26), less than Revolution Medicines, Inc. (14.24), greater than Blueprint Medicines Corporation (3.32), less than Kymera Therapeutics, Inc. (8.55), less than Monte Rosa Therapeutics, Inc. (6.03), less than Nkarta, Inc. (12.91), less than Lyell Immunopharma, Inc. (13.43), less than Generation Bio Co. (6.34), less than Mirati Therapeutics, Inc. (7.54), less than Amylyx Pharmaceuticals, Inc. (4.55), greater than Apellis Pharmaceuticals, Inc. (4.36),

Build a custom stock screener for Sana Biotechnology, Inc. (SANA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sana Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sana Biotechnology, Inc. (SANA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sana Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.